NASDAQ:ASPX - Auspex Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$100.96
Today's RangeN/A
52-Week Range$14.75 - $101.00
VolumeN/A
Average Volume1.02 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.

Receive ASPX News and Ratings via Email

Sign-up to receive the latest news and ratings for ASPX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:ASPX
Previous Symbol
CUSIPN/A
WebN/A
Phone+1-858-5582400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Auspex Pharmaceuticals (NASDAQ:ASPX) Frequently Asked Questions

What is Auspex Pharmaceuticals' stock symbol?

Auspex Pharmaceuticals trades on the NASDAQ under the ticker symbol "ASPX."

How were Auspex Pharmaceuticals' earnings last quarter?

Auspex Pharmaceuticals Inc (NASDAQ:ASPX) issued its earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.59) by $0.15. View Auspex Pharmaceuticals' Earnings History.

Has Auspex Pharmaceuticals been receiving favorable news coverage?

Media stories about ASPX stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Auspex Pharmaceuticals earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Auspex Pharmaceuticals?

Shares of ASPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Auspex Pharmaceuticals?

Auspex Pharmaceuticals' mailing address is 3333 N Torrey Pines Ct Ste 400, LA JOLLA, CA 92037-1023, United States. The biopharmaceutical company can be reached via phone at +1-858-5582400.


MarketBeat Community Rating for Auspex Pharmaceuticals (NASDAQ ASPX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  218
MarketBeat's community ratings are surveys of what our community members think about Auspex Pharmaceuticals and other stocks. Vote "Outperform" if you believe ASPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Featured Article: What is Compound Interest?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel